Most people recognize Alzheimer’s from its devastating symptoms such as memory loss, while new drugs target pathological aspects of disease manifestations, such as plaques of amyloid proteins. Now a sweeping new study in the journal Cell by MIT researchers shows the importance of understanding the disease as a battle over how well brain cells control the expression of their genes.